CVS 건강 공사
| Security | CVS / CVS Health Corporation |
| Insider | Roger N Farah |
This page shows the track record and history of FARAH ROGER N
insider trades in CVS Health Corporation. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Roger N Farah in CVS / CVS Health Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Roger N Farah in CVS / CVS Health Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-02 | 2025-11-30 | 4 | FARAH ROGER N | CVS | Common Stock | D | 80.3600 | -9,748 | -783 | 19,438 | ||||
| 2024-12-03 | 2024-11-30 | 4 | FARAH ROGER N | CVS | Common Stock (Restricted) | D | 59.8500 | 50,125 | 3,000 | 50,125 | ||||
| 2022-05-13 | 2022-05-11 | 4 | FARAH ROGER N | CVS | Share Credits | D | 0.00 | 97.9900 | 3,113 | 305 | 17,084 | |||
| 2021-11-19 | 2021-11-17 | 4 | FARAH ROGER N | CVS | Share Credits | D | 0.00 | 92.7300 | 1,672 | 155 | 13,899 | |||
| 2021-05-14 | 2021-05-13 | 4 | FARAH ROGER N | CVS | Share Credits | D | 0.00 | 84.2700 | 1,839 | 155 | 12,087 | |||
| 2020-11-20 | 2020-11-18 | 4 | FARAH ROGER N | CVS | Share Credits | D | 0.00 | 66.3500 | 2,336 | 155 | 10,112 | |||
| 2020-05-15 | 2020-05-14 | 4 | FARAH ROGER N | CVS | Share Credits | D | 0.00 | 62.3100 | 2,488 | 155 | 7,649 | |||
| 2019-11-22 | 2019-11-20 | 4 | FARAH ROGER N | CVS | Share Credits | D | 0.00 | 74.9200 | 2,069 | 155 | 5,081 | |||
| 2019-05-20 | 2019-05-16 | 4 | FARAH ROGER N | CVS | Share Credits | D | 0.00 | 52.3000 | 2,964 | 155 | 2,964 | |||
| 2018-11-30 | 3 | FARAH ROGER N | CVS | Common Stock | D | 7,642 | ||||||||
| 2018-11-30 | 3 | FARAH ROGER N | CVS | Common Stock | D | 7,642 | ||||||||
| 2018-11-30 | 3 | FARAH ROGER N | CVS | Common Stock | D | 7,642 | ||||||||
| 2018-11-30 | 2018-11-28 | 4 | FARAH ROGER N | CVS | Common Stock | D | 2,513 | 3,821 | ||||||
| 2018-11-30 | 2018-11-28 | 4 | FARAH ROGER N | CVS | Common Stock | D | 80.2700 | 1,308 | 105 | 1,308 |
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)
